News
We bring you up to date at all times: Discover the latest industry news from biotechnology, pharmaceuticals and life sciences. Researched by us so you don't have to.
Selected departments
Selected industries
Companies
The Who's Who of Life Sciences: Discover companies from all over the world. Here you can easily find the provider matching your search, including contact options.
Selected countries
Selected companies
Products
The first stop for your procurement process: discover innovative products for lab and process that make your everyday life easier and solve even complex challenges.
Products of selected companies
White papers
What could be better than an application problem that has already been solved by others? Tap into in-depth application knowledge from proven experts. Conveniently via download to your device.
Most read white papers
White papers of selected companies
Webinars
Exciting lectures and practical application tips via video, whenever you want: Our on-demand webinars make it possible. Make yourself comfortable and click play.
Selected webinars
Webinars of selected companies
Knowledge & education
Question. Answer. Find articles on 57,945 keywords in life science, biotech, pharma, biology and related science disciplines in the encyclopedia..
From now on, don't miss a thing: Our newsletter for biotechnology, pharma and life sciences brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.
Note
The function "Store search" is only available to registered users.
Important information
Currently, you are not logged in to my.bionity.com. Therefore, you can remember a maximum of 5 contents.
FILTER
Refine your search with the following facets to narrow down your results.
21-Jul-2006 - CuraGen Corporation has been informed by Bayer Pharmaceuticals Corporation that Bayer plans to license BAY 76-7171 (formerly CT052). BAY 76-7171 was discovered under an ongoing metabolic disorder collaboration between CuraGen and Bayer aimed at identifying and developing potential small molecule ...
Grants Awarded to Develop Faster, Cheaper DNA Sequencing
29-May-2006 - The National Human Genome Research Institute (NHGRI), part of the National Institutes of Health (NIH), announced it has awarded grants totaling more than $32 million to advance the development of innovative sequencing technologies intended to reduce the cost of DNA sequencing and expand the use ...
11-Apr-2006 - Ablynx has announced that its drug discovery and development alliance with Procter & Gamble Pharmaceuticals, Inc. (P&GP), a subsidiary of The Procter & Gamble Company, has been extended to include metabolic disease targets. Through this agreement, Ablynx will use its unique and patent protected ...
22-Mar-2006 - Exelixis, Inc. and Sankyo Company (a wholly owned subsidiary of DAIICHI SANKYO COMPANY, LIMITED) announced a collaboration agreement to discover, develop and commercialize novel therapies targeted against the mineralocorticoid receptor (MR), a nuclear hormone receptor (NHR) implicated in a ...
17-Mar-2006 - Global Life Science Ventures (GLSV) announced an investment in Santaris Pharma A/S in a Series B financing round totalling EUR40 million, as part of a syndicate led by ABN AMRO Capital Life Science and also including BankInvest, Novo Ventures, LD Pensions, Væksfonden, SPEF Ventures, ...
16-Mar-2006 - Transition Therapeutics Inc. announced the signing of an exclusive license agreement to a patent portfolio for the use of Glucagon-Like Peptide-1 ("GLP-1") analogues in the treatment of Type I diabetes. The Patent Portfolio includes two issued US patents (US No. 6,989,148 & US No. 6,899,883). The ...
10-Mar-2006 - Crucell N.V. and allied contract manufacturer DSM Biologics announced that they have signed a PER.C6® research license agreement with Japanese pharmaceutical company UMN Pharma. This license agreement allows UMN Pharma to use the PER.C6® cell line in its 'UMN-03' project, which aims to employ a ...
23-Feb-2006 - Cambrex Bio Science Walkersville, Inc., a subsidiary of Cambrex, announced that its client Chugai Pharmaceutical Co., Ltd. completed their assessment of certain of its Clonetics(R) Conditionally Immortalized Cell Lines under the previously announced evaluation license and signed a one-year ...
14-Feb-2006 - Amgen and Biovitrum AB announced that they have expanded their existing agreement under which Amgen will now receive exclusive worldwide rights to develop and commercialize Biovitrum's small molecule 11(beta)-HSD1 enzyme inhibitors for the treatment of metabolic diseases and certain other medical ...
17-Jan-2006 - CV Therapeutics, Inc. announced that it has appointed Joseph M. Davie, M.D., Ph.D., to the company's board of directors. Dr. Davie, former senior vice president of research at Biogen, Inc., also previously held senior level research positions with G.D. Searle & Co., and led the department of ...
© 1997-2024 LUMITOS AG, All rights reserved